CEL-SCI Corporation | Finanzwire

Basculer en Français

10753	Companies
230920	Keywords
159355	Articles
122728	Press releases

Home
Companies
CEL-SCI Corporation

BRIEF

published on 07/20/2026 at 16:03, 1 day ago

CEL-SCI Corporation: Strategic Partnership with Amarox and Updated Price Target

Strategic Partnership CEL-SCI Corporation Multikine Amarox Price Target Update
PRESS RELEASE

published on 07/20/2026 at 15:58, 1 day ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research provides an update on CEL-SCI Corporation, maintaining Buy rating with a revised target price of USD 15. The company's partnership with Amarox and upcoming clinical milestones are highlighted

BUY Rating CEL-SCI Corporation Clinical Milestones Amarox Partnership USD 15 Target Price
BRIEF

published on 09/01/2025 at 13:43, 10 months 20 days ago

CEL-SCI Corporation Nears Key Commercial Milestones

Saudi Arabia Funding CEL-SCI Corporation Multikine Breakthrough Medicine
PRESS RELEASE

published on 09/01/2025 at 13:38, 10 months 20 days ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for CEL-SCI Corp. following key developments in Saudi Arabia and US. Price target revised to USD 60

Saudi Arabia Buy Recommendation Price Target Immunotherapy CEL-SCI Corp.
BRIEF

published on 09/04/2024 at 12:36, 1 year 10 months ago

First Berlin Equity Research Reiterates Buy Rating for CEL-SCI Corporation

Financial Results FDA Approval Multikine First Berlin Equity CEL-SCI
PRESS RELEASE

published on 09/04/2024 at 12:31, 1 year 10 months ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on CEL-SCI Corp. Analyst reiterates Buy rating and USD 6.20 target price. Positive results from financials and bias analysis

First Berlin Equity Research BUY Rating CEL-SCI Corporation USD 6.20 Target Price Bias Analysis
BRIEF

published on 06/11/2024 at 10:41, 2 years 1 month ago

First Berlin Equity Research Reaffirms Buy Recommendation for CEL-SCI Corporation

FDA Approval Clinical Study CEL-SCI Corporation Multikine Equity Research
PRESS RELEASE

published on 06/11/2024 at 10:36, 2 years 1 month ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for CEL-SCI Corporation after FDA's positive outcome on Multikine's type B meeting, adjusting price target to USD 6.20

FDA First Berlin Equity Research Stock Market CEL-SCI Corporation Multikine
PRESS RELEASE

published on 02/14/2024 at 15:51, 2 years 5 months ago

Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms BUY rating for CEL-SCI Corporation (ISIN: US1508376076) with USD 8.40 price target. Completion of US manufacturing facility for lead drug Multikine expected in H1 2024

First Berlin Equity Research CEL-SCI Corporation Multikine US Manufacturing Facility USD 8.40 Price Target

Accesswire

Published on 07/21/2026 at 15:00, 1 hour 33 minutes ago

Four Nines Gold Begins Maiden Drill Program at Hayden Hill
Published on 07/21/2026 at 15:00, 1 hour 33 minutes ago

BlackBerry SecuSUITE Secures Renewed NIAP Common Criteria Certification, Reinforcing Leadership in Sovereign Government-Grade Secure Communications
Published on 07/21/2026 at 14:55, 1 hour 38 minutes ago

Vulcan Minerals Inc. - Drilling Completed at Carbonear Zinc-Lead SEDEX Project in Newfoundland
Published on 07/21/2026 at 14:30, 2 hours 3 minutes ago

Sarama Completes Sale of its West Australian Gold Assets
Published on 07/21/2026 at 14:30, 2 hours 3 minutes ago

Hillcrest Announces Shares for Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 07/21/2026 at 16:15, 18 minutes ago

Shelly Group announces terms of dividend payment
Published on 07/21/2026 at 16:05, 28 minutes ago

Omio Group to acquire Rail Europe to consolidate the ground transportation landscape
Published on 07/21/2026 at 15:53, 39 minutes ago

OHB Strengthens Argonaut Lunar Mission with MDA Space Landing Sensor Partnership
Published on 07/21/2026 at 15:49, 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/21/2026 at 15:48, 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 07/20/2026 at 18:20, 22 hours 13 minutes ago

Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 22 hours 28 minutes ago

Reporting on share buyback transactions carried out between July 8 and July 9, 2026
Published on 07/20/2026 at 17:45, 22 hours 48 minutes ago

Weekly share buyback
Published on 07/20/2026 at 17:40, 22 hours 53 minutes ago

Mersen selected to supply Ford and Leapmotor with fuses for electric vehicles
Published on 07/20/2026 at 14:25, 1 day 2 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from July 13 to July 17 2026

View all LES ECHOS COMFI WIRE